CoQ10 and Mitochondrial Dysfunction in Alzheimer's Disease

Zdeněk Fišar,Jana Hroudová

DOI: https://doi.org/10.3390/antiox13020191

IF: 7.675

2024-02-03

Antioxidants

Abstract:The progress in understanding the pathogenesis and treatment of Alzheimer's disease (AD) is based on the recognition of the primary causes of the disease, which can be deduced from the knowledge of risk factors and biomarkers measurable in the early stages of the disease. Insights into the risk factors and the time course of biomarker abnormalities point to a role for the connection of amyloid beta (Aβ) pathology, tau pathology, mitochondrial dysfunction, and oxidative stress in the onset and development of AD. Coenzyme Q10 (CoQ10) is a lipid antioxidant and electron transporter in the mitochondrial electron transport system. The availability and activity of CoQ10 is crucial for proper mitochondrial function and cellular bioenergetics. Based on the mitochondrial hypothesis of AD and the hypothesis of oxidative stress, the regulation of the efficiency of the oxidative phosphorylation system by means of CoQ10 can be considered promising in restoring the mitochondrial function impaired in AD, or in preventing the onset of mitochondrial dysfunction and the development of amyloid and tau pathology in AD. This review summarizes the knowledge on the pathophysiology of AD, in which CoQ10 may play a significant role, with the aim of evaluating the perspective of the pharmacotherapy of AD with CoQ10 and its analogues.

biochemistry & molecular biology,chemistry, medicinal,food science & technology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of coenzyme Q10 (CoQ10) in Alzheimer's disease (AD), especially how it affects mitochondrial dysfunction and oxidative stress. Specifically, the paper focuses on the following aspects:

1. **The relationship between mitochondrial dysfunction and AD**: The paper discusses the crucial role of mitochondrial dysfunction in the pathogenesis of AD, including reduced ATP production, increased production of reactive oxygen species (ROS), release of pro - apoptotic factors, and disordered calcium homeostasis.

2. **The mechanism of action of CoQ10**: CoQ10 is a lipid - soluble antioxidant and an important electron carrier in the mitochondrial electron transport chain. The paper elaborates on the role of CoQ10 in maintaining mitochondrial function and cellular bioenergetics, including its regulatory role in the oxidative phosphorylation system (OXPHOS).

3. **The potential of CoQ10 in AD treatment**: Based on the mitochondrial hypothesis and the oxidative stress hypothesis, the paper evaluates the potential of supplementing CoQ10 or its analogues to restore the impaired mitochondrial function in AD, or to prevent mitochondrial dysfunction and the development of amyloid and tau protein pathologies.

4. **The pathophysiology of AD**: The paper summarizes the pathophysiological characteristics of AD, especially the inter - relationships between amyloid (Aβ) and tau protein pathologies and mitochondrial dysfunction and oxidative stress.

Through these discussions, the paper aims to provide a new perspective for the drug treatment of AD, especially using CoQ10 and its analogues as potential treatment means.